Clinical Study
Completely Resected N0 Non-Small Cell Lung Cancer: Prognostic Factors Affecting Long-Term Survival
Table 3
Univariable analysis of overall survival in completely resected NSCLC without nodal involvement by Cox proportional hazard model.
| Parameters | Hazard ratio | 95% confident interval | value |
| Age (year) | | | | <60 | Reference | | | 60–69 | 1.7 | 0.8–3.7 | 0.157 | ≥70 | 2.5 | 1.2–5.3 | 0.018 | Male | 1.4 | 0.8–2.5 | 0.258 | Smoking | 1.3 | 0.8–2.2 | 0.257 | COPD | 1.8 | 0.9–3.6 | 0.099 | Histologic grading | 1.0 | 0.9–1.2 | 0.764 | Histologic cell type | 1.0 | 0.9–1.3 | 0.466 | Staging of lung cancer | | | | IA | Reference | | | IB | 1.4 | 0.6–3.1 | 0.376 | IIA | 2.4 | 0.9–5.7 | 0.057 | IIB | 2.9 | 1.2–7.0 | 0.015 | Tumor size >3 cm | 1.9 | 0.9–4.0 | 0.078 | Visceral pleural invasion | 1.2 | 0.6–2.4 | 0.685 | Intratumoral vascular invasion | 1.5 | 0.8–2.7 | 0.195 | Intratumoral lymphatic invasion | 1.5 | 0.7–3.1 | 0.276 | Tumor necrosis | 2.2 | 1.2–3.9 | 0.007 | Tumor recurrence | 4.7 | 2.4–9.3 | <0.001 | Lung metastasis | 1.3 | 0.7–2.5 | 0.351 | Pleural metastasis | 4.2 | 0.9–17.6 | 0.053 | Bone metastasis | 1.7 | 0.6–4.7 | 0.323 | Brain metastasis | 5.2 | 2.6–10.3 | <0.001 | Liver metastasis | 1.1 | 0.1–7.7 | 0.958 | Chest wall metastasis | 4.9 | 0.7–36.8 | 0.119 | Adrenal metastasis | 24.1 | 2.8–205.9 | 0.004 | Renal metastasis | 8.7 | 1.1–66.5 | 0.037 | Skin metastasis | 7.9 | 2.7–22.9 | <0.001 |
|
|